Financhill
Sell
48

PTGX Quote, Financials, Valuation and Earnings

Last price:
$40.57
Seasonality move :
28.98%
Day range:
$38.91 - $41.68
52-week range:
$21.43 - $48.89
Dividend yield:
0%
P/E ratio:
15.60x
P/S ratio:
7.92x
P/B ratio:
4.65x
Volume:
2.3M
Avg. volume:
836.9K
1-year change:
99.95%
Market cap:
$2.5B
Revenue:
$60M
EPS (TTM):
$2.66

Earnings Data

Next earnings date for PTGX
Feb 27
2025
Most recent earnings per share
-$0.54
Missed by $0.01
(Nov 7/2024)
Consensus Estimate
-$0.53
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PTGX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/27/2025 Q4 $53.5M -- -- $0.15 --
11/07/2024 Q3 $1.8M $4.7M -$0.54 -$0.53 -$0.01
08/06/2024 Q2 $6.7M $4.2M -$0.50 -$0.41 -$0.09
05/07/2024 Q1 $120M $255M $3.26 $1.60 $1.66
02/27/2024 Q4 $30M $60M $0.44 -$0.18 $0.62
11/02/2023 Q3 -- -- -$0.58 -$0.70 $0.12
08/03/2023 Q2 -- -- -$0.68 -$0.66 -$0.02
05/04/2023 Q1 -- -- -$0.67 -$0.70 $0.03
03/15/2023 Q4 -- -- -$0.69 -$0.61 -$0.08
11/08/2022 Q3 -- -- -$0.64 -$0.82 $0.18
08/04/2022 Q2 -- -- -$0.84 -$0.98 $0.14
05/04/2022 Q1 -- -- -$0.43 -$0.60 $0.17
02/28/2022 Q4 -- -- -$0.77 -$0.76 -$0.01
11/03/2021 Q3 -- -- -$0.70 -$0.66 -$0.04
08/04/2021 Q2 -- -- -$0.69 -$0.53 -$0.16
05/04/2021 Q1 -- -- -$0.54 -$0.57 $0.02
03/10/2021 Q4 -- -- -$0.48 -$0.47 -$0.01
11/04/2020 Q3 -- -- -$0.21 -$0.56 $0.35
08/06/2020 Q2 -- -- -$0.59 -$0.59 -$0.01
05/07/2020 Q1 -- -- -$0.72 -$0.68 -$0.04
03/10/2020 Q4 -- -- -$0.63 -$0.70 $0.07
11/06/2019 Q3 -- -- -$0.61 -$0.73 $0.12
08/07/2019 Q2 -- -- -$1.18 -$0.27 -$0.91
05/08/2019 Q1 -- -- -$0.58 -$0.63 $0.05
03/12/2019 Q4 -- -- -$0.57 -$0.47 -$0.10
11/06/2018 Q3 -- -- -$0.38 -$0.33 -$0.05
08/07/2018 Q2 -- -- -$0.41 -$0.29 -$0.12
05/09/2018 Q1 -- -- -$0.36 -$0.24 -$0.12
03/07/2018 Q4 -- -- -$0.15 -$0.37 $0.22
11/06/2017 Q3 -- -- -$0.29 -$0.61 $0.32
08/08/2017 Q2 -- -- -$0.89 -$0.81 -$0.08
03/31/2017 Q1 -- -- -$0.84 -$0.60 -$0.25

Protagonist Therapeutics Earnings Questions

  • How Much did Protagonist Therapeutics Generate in Revenue Last Quarter?

    Protagonist Therapeutics reported $4.7M worth of top line sales in its most recent quarter.

  • Did Protagonist Therapeutics Beat Earnings Last Quarter?

    Protagonist Therapeutics announced earnings per share of -$0.54 which represents a miss of analyst forecast a -$0.53 per share.

  • Is Protagonist Therapeutics Profitable?

    Protagonist Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Protagonist Therapeutics EPS Next Year?

    Protagonist Therapeutics's earnings are forecast to decrease from -$1.39 per share to -$2.04 per share next year representing a decrease of -59.85%.

  • When is Protagonist Therapeutics's Earnings Date?

    Protagonist Therapeutics's next earnings date is February 27, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 3.8% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 6.65% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock